Liu SY, Song JC, Mao HD, et al. Expert consensus on the diagnosis and treatment of heat stroke in China[J]. Mil Med Res, 2020, 7(1): 1.

Martínez-Solanas È, Quijal-Zamorano M, Achebak H, et al. Projections of temperature-attributable mortality in Europe: a time series analysis of 147 contiguous regions in 16 countries[J]. Lancet Planet Health, 2021, 5(7): e446-e454.

Han QM, Liu Z, Jia JW, et al. Web-based data to quantify meteorological and geographical effects on heat stroke: case study in China[J]. GeoHealth, 2022, 6(8): e2022GH000587.

Pan RR, Xie M, Chen MX, et al. The impact of heat waves on the mortality of Chinese population: a systematic review and meta-analysis[J]. Medicine, 2023, 102(13): e33345.

Iba T, Helms J, Levi M, et al. Inflammation, coagulation, and cellular injury in heat-induced shock[J]. Inflamm Res, 2023, 72(3): 463-473.

Wright DO, Reppert LB, Cuttino JT. Purpuric manifestations of heatstroke; studies of prothrombin and platelets in 12 cases[J]. Arch Intern Med, 1946, 77: 27-36.

Misset B, de Jonghe B, Bastuji-Garin S, et al. Mortality of patients with heatstroke admitted to intensive care units during the 2003 heat wave in France: a national multiple-center risk-factor study[J]. Crit Care Med, 2006, 34(4): 1087-1092.

Hifumi T, Kondo Y, Shimazaki J, et al. Prognostic significance of disseminated intravascular coagulation in patients with heat stroke in a nationwide registry[J]. J Crit Care, 2018, 44: 306-311.

JrClowes GH, JrO'Donnell TF. Heat stroke[J]. N Engl J Med, 1974, 291(11): 564-567.

Ellis FP. Heat illness. I. epidemiology[J]. Trans R Soc Trop Med Hyg, 1976, 70(5/6): 402-411.

Glazer JL. Management of heatstroke and heat exhaustion[J]. Am Fam Physician, 2005, 71(11): 2133-2140.

Bouchama A, Abuyassin B, Lehe C, et al. Classic and exertional heatstroke[J]. Nat Rev Dis Primers, 2022, 8(1): 8.

Sithinamsuwan P, Piyavechviratana K, Kitthaweesin T, et al. Exertional heatstroke: early recognition and outcome with aggressive combined cooling: a 12-year experience[J]. Mil Med, 2009, 174(5): 496-502.

Vesić Z, Vukasinović-Vesić M, Dincić D, et al. The effects of acclimatization on blood clotting parameters in exertional heat stress[J]. Vojnosanit Pregl, 2013, 70(7): 670-674.

Veltmeijer MTW, Eijsvogels TMH, Barteling W, et al. The impact of exercise-induced core body temperature elevations on coagulation responses[J]. J Sci Med Sport, 2017, 20(2): 202-207.

Abhilash KP, Raju F, Biju A, et al. The effects of temperature and outcomes of patients presenting to the emergency department with heat-related illness: a retrospective cross-sectional study[J]. Int J Acad Med, 2021, 7(4): 220.

JrO'Donnell TF. Acute heat stroke. Epidemiologic, biochemical, renal, and coagulation studies[J]. JAMA, 1975, 234(8): 824-828.

Boersma LV, Leyten QH, Meijer JW, et al. Cerebral hemorrhage complicating exertional heat stroke[J]. Clin Neurol Neurosurg, 1998, 100(2): 112-115.

Malamud N, Haymaker W, Custer RP. Heat stroke: a clinico-pathologic study of 125 fatal cases[J]. Mil Surg, 1946, 99(5): 397-449.

Huisse MG, Pease S, Hurtado-Nedelec M, et al. Leukocyte activation: the link between inflammation and coagulation during heatstroke. A study of patients during the 2003 heat wave in Paris[J]. Crit Care Med, 2008, 36(8): 2288-2295.

Zhang ZT, Gu XL, Zhao X, et al. NLRP3 ablation enhances tolerance in heat stroke pathology by inhibiting IL-1β-mediated neuroinflammation[J]. J Neuroinflammation, 2021, 18(1): 128.

Li Y, Zhu XT, Wang GZ, et al. Proteomic analysis of extracellular vesicles released from heat-stroked hepatocytes reveals promotion of programmed cell death pathway[J]. Biomed Pharmacother, 2020, 129: 110489.

Geng Y, Ma Q, Liu YN, et al. Heatstroke induces liver injury via IL-1β and HMGB1-induced pyroptosis[J]. J Hepatol, 2015, 63(3): 622-633.

Hirose T, Hamaguchi S, Matsumoto N, et al. Presence of neutrophil extracellular traps and citrullinated histone H3 in the bloodstream of critically ill patients[J]. PLoS One, 2014, 9(11): e111755.

Rosenthal T, Shapiro Y, Seligsohn U, et al. Disseminated intravascular coagulation in experimental heatstroke[J]. Thromb Diath Haemorrh, 1971, 26(3): 417-425.

Bouchama A, Hammami MM, Haq A, et al. Evidence for endothelial cell activation/injury in heatstroke[J]. Crit Care Med, 1996, 24(7): 1173-1178.

He LP, Song JC, Peng EL, et al. Diagnostic value of thrombomodulin and tissue plasmin activator plasmin activator inhibitor-1 complex in heat stroke [J]. J Clin Laboratory, 2023, 41(1): 17-21.

何龙平, 宋景春, 彭恩兰, 等. 血栓调节蛋白和组织纤溶酶原激活物-纤溶酶原激活物抑制剂-1复合物在热射病中的诊断价值[J]. 临床检验杂志, 2023, 41(1): 17-21.

al-Mashhadani SA, Gader AG, al Harthi SS, et al. The coagulopathy of heat stroke: alterations in coagulation and fibrinolysis in heat stroke patients during the pilgrimage (Haj) to Makkah[J]. Blood Coagul Fibrinolysis, 1994, 5(5): 731-736.

Lim CL. Heat sepsis precedes heat toxicity in the pathophysiology of heat stroke-a new paradigm on an ancient disease[J]. Antioxidants (Basel), 2018, 7(11): 149.

Mohanty D, Gomez J, Mustafa KY, et al. Pathophysiology of bleeding in heat stress: an experimental study in sheep[J]. Exp Hematol, 1997, 25(7): 615-619.

Shibolet S, Fisher S, Gilat T, et al. Fibrinolysis and hemorrhages in fatal heatstroke[J]. N Engl J Med, 1962, 266: 169-173.

Bouchama A, Bridey F, Hammami MM, et al. Activation of coagulation and fibrinolysis in heatstroke[J]. Thromb Haemost, 1996, 76(6): 909-915.

Aoki K, Yoshino A, Ueda Y, et al. Severe heat stroke associated with high plasma levels of plasminogen activator inhibitor 1[J]. Burns, 1998, 24(1): 74-77.

Veltmeijer MT, Eijsvogels TM, Thijssen DH, et al. Incidence and predictors of exertional hyperthermia after a 15-km road race in cool environmental conditions[J]. J Sci Med Sport, 2015, 18(3): 333-337.

Dou JL, Song JC, Yu T, et al. Characteristics of coagulation dysfunction in rats with heat stroke induced by exertional heat illness at different core temperatures [J]. Trauma and Cri Care Med, 2022, 10(2): 92-96.

窦建林, 宋景春, 余甜, 等. 不同核心温度下劳力性热射病大鼠凝血功能障碍特征研究[J]. 创伤与急危重病医学, 2022, 10(2): 92-96.

Mégarbane B, Résière D, Shabafrouz K, et al. Descriptive study of the patients admitted to an intensive care unit during the heat wave of August 2003 in France[J]. Presse Med, 2003,32(36):1690-1698.

Pan ZG, Shao Y, Liu YN, et al. Relationship between early coagulability parameters at admission and outcome in patients with severe heatstroke[J]. Chin Crit Care Med, 2013, 25(12): 725-728.

潘志国, 邵玉, 刘亚楠, 等. 重症中暑患者入院早期凝血功能指标与预后的关系[J]. 中华危重病急救医学, 2013, 25(12): 725-728.

Bouchama A, Knochel JP. Heat stroke[J]. N Engl J Med, 2002, 346(25): 1978-1988.

Hifumi T, Kondo Y, Shimizu K, et al. Heat stroke[J]. J Intensive Care, 2018, 6: 30.

Lin QW,Zhong LC, He LP, et al. A newly proposed heatstroke-induced coagulopathy score in patients with heat illness: a multicenter retrospective study in China[J]. Chin J Traumatol, 2023:S1008-1275(23)00070-6. DOI: 10.1016/j.cjtee.2023.08.001http://dx.doi.org/10.1016/j.cjtee.2023.08.001. Online ahead of print.

JrTaylor FB, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation[J]. Thromb Haemost, 2001, 86(5): 1327-1330.

Zeng QB, Song JC, Lin QW, et al. The value of thromboelastography in diagnosis and prognostic judgment of heat stroke complicated with diffuse intravascular coagulation[J]. J Med PLA, 2018, 43(9): 752-755.

曾庆波, 宋景春, 林青伟, 等. 血栓弹力图对热射病合并弥散性血管内凝血的诊断及预后判断价值[J]. 解放军医学杂志, 2018, 43(9): 752-755.

Wan P, Tong HS, Zhang XQ, et al. The diagnostic value of Sonoclot analyzer in severe heatstroke complicated with disseminated intravascular coagulation[J]. J Prac Med, 2014, 30(16): 2562-2565.

万鹏, 童华生, 张兴钦, 等. Sonoclot分析仪在重症中暑并发弥散性血管内凝血中的诊断价值[J]. 实用医学杂志, 2014, 30(16): 2562-2565.

Othman M, Kaur H. Thromboelastography (TEG)[J]. Methods Mol Biol, 2017, 1646: 533-543.

He LP, Lin QW, Zhong LC, et al. Thromboelastography maximum amplitude as an early predictor of disseminated intravascular coagulation in patients with heatstroke[J]. Int J Hyperthermia, 2022, 39(1): 605-610.

Hett DA, Walker D, Pilkington SN, et al. Sonoclot analysis[J]. Br J Anaesth, 1995, 75(6): 771-776.

Min JY, Wan P, Liu GW, et al. Sonoclot signature analysis: a new point-of-care testing method for defining heat stroke-induced coagulopathy[J]. Int J Gen Med, 2021, 14: 6925-6933.

Katayama S, Nunomiya S, Koyama K, et al. Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin[J]. Crit Care, 2017, 21(1): 229.

Niwano H, Takahashi H, Tatewaki W, et al. Behaviour of tissue plasminogen activator, plasminogen activator inhibitor 1 and their complex in various disease states[J]. Blood Coagul Fibrinolysis, 1992, 3(4): 389-393.

Koller L, Sulzgruber P, Scharnagl H, et al. Prognostic significance of tPA/PAI-1 complex in patients with heart failure and preserved ejection fraction[J]. Thromb Haemost, 2017, 117(3): 471-478.

Zhong LC, Dou JL, Lin QW, et al. Tissue-type plasminogen activator-inhibitor complex as an early predictor of septic shock: a retrospective, single-center study[J]. Dis Markers, 2022, 2022: 9364037.

Liu SY, Song JC, Mao HD, et al. Consensus of experts on the diagnosis and treatment of heatstroke in China[J]. J Med PLA, 2019, 44(3): 181-196.

刘树元, 宋景春, 毛汉丁, 等. 中国热射病诊断与治疗专家共识[J]. 解放军医学杂志, 2019, 44(3): 181-196.

Miller KC, Hughes LE, Long BC, et al. Validity of core temperature measurements at 3 rectal depths during rest, exercise, cold-water immersion, and recovery[J]. J Athl Train, 2017, 52(4): 332-338.

Weber MB, Blakely JA. The haemorrhagic diathesis of heatstroke. A consumption coagulopathy successfully treated with heparin[J]. Lancet, 1969, 1(7607): 1190-1192.

Iba T, Connors JM, Levi M, et al. Heatstroke-induced coagulopathy: Biomarkers, mechanistic insights, and patient management[J]. EClinicalMedicine, 2022, 44: 101276.

Yatabe T, Inoue S, Sakamoto S, et al. The anticoagulant treatment for sepsis induced disseminated intravascular coagulation; network meta-analysis[J]. Thromb Res, 2018, 171: 136-142.

Group of Thrombosis and Hemostasis, Branchhematology, Chinese Medical Association. Chinese expert consensus on diagnosis and treatment of disseminated intravascular coagulation (2012)[J]. Chin J Hematol, 2012, 33(11): 978-979.

中华医学会血液学分会血栓与止血学组. 弥散性血管内凝血诊断与治疗中国专家共识(2012年版)[J]. 中华血液学杂志, 2012, 33(11): 978-979.

Li YT, Guo CW, Liu H, et al. Comparison of the effect of low molecular weight heparin sodium and that of heparin sodium on pre-disseminated intravascular coagulation stage in patients suffering from exertional heat stroke[J]. Chin Crit Care Med, 2015, 27(8): 649-652.

李玉堂, 郭春文, 刘辉, 等. 低分子肝素钠与普通肝素钠治疗劳力性热射病非显性弥散性血管内凝血的比较研究[J]. 中华危重病急救医学, 2015, 27(8): 649-652.

Zheng AR, Zhang W, Li C, et al. The heparinase-linked differential time method allows detection of heparin potency in whole blood with high sensitivity and dynamic range[J]. Biosens Bioelectron, 2022, 198: 113856.

Quinn TM, Gaughan EE, Bruce A, et al. Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics[J]. EBioMedicine, 2022, 76: 103856.

Umemura Y, Yamakawa K, Ogura H, et al. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials[J]. J Thromb Haemost, 2016, 14(3): 518-530.

Takahashi W, Yoneda T, Koba H, et al. Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation[J]. Int J Infect Dis, 2021, 102: 529-531.

Minakata D, Fujiwara SI, Hayakawa J, et al. Comparison of danaparoid sodium and synthetic protease inhibitors for the treatment of disseminated intravascular coagulation associated with hematological malignancies: a retrospective analysis[J]. Acta Haematol, 2020, 143(3): 250-259.

Minakata D, Fujiwara SI, Ikeda T, et al. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies[J]. Int J Hematol, 2019, 109(2): 141-146.

Kusuzawa K, Suzuki K, Okada H, et al. Measuring the concentration of serum syndecan-1 to assess vascular endothelial glycocalyx injury during hemodialysis[J]. Front Med, 2021, 8: 791309.

Lin QW, Song JC, Peng EL, et al. Discussion on the treatment of sepsis-induced coagulopathy with nafamostat mesilate[J]. Thromb & Haemost, 2023, 29(3): 138-142.

林青伟, 宋景春, 彭恩兰, 等. 应用甲磺酸萘莫司他治疗脓毒症性凝血病的探讨[J]. 血栓与止血学, 2023, 29(3): 138-142.

Lin QW, Peng EL, Zhang X, et al. Sequential anticoagulation combined with immunosorbent therapy for symmetrical peripheral gangrene[J]. J Clin Lab Med, 2023, 41(4): 315-318.

林青伟, 彭恩兰, 张昕, 等. 序贯抗凝联合免疫吸附治疗对称性周围肢端坏疽[J]. 临床检验杂志, 2023, 41(4): 315-318.

Kamijo H, Mochizuki K, Nakamura Y, et al. Nafamostat mesylate improved survival outcomes of sepsis patients who underwent blood purification: a nationwide registry study in Japan[J]. J Clin Med, 2020, 9(8): 2629.

Squizzato A, Hunt BJ, Kinasewitz GT, et al. Supportive management strategies for disseminated intravascular coagulation. An international consensus[J]. Thromb Haemost, 2016, 115(5): 896-904.

Rossaint R, Afshari A, Bouillon B, et al. The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition[J]. Crit Care, 2023, 27(1): 80.

Waters JH. Role of the massive transfusion protocol in the management of haemorrhagic shock[J]. Br J Anaesth, 2014, 113(Suppl 2): ii3-ii8.

Peng HT, Nascimento B, Beckett A. Thromboelastography and thromboelastometry in assessment of fibrinogen deficiency and prediction for transfusion requirement: a descriptive review[J]. Biomed Res Int, 2018, 2018: 7020539.

He LP, Lin QW, Deng XP, et al. Study on the timing of thromboelastography guided wound coagulation factor replacement therapy[J]. J Clin Mili Med, 2022, 50(7): 725-728, 732.

何龙平, 林青伟, 邓星平, 等. 血栓弹力图指导创伤凝血因子替代治疗时机研究[J]. 临床军医杂志, 2022, 50(7): 725-728, 732.

Zhong LC, Lin QW, Qi Y, et al. Application of fibrinogen function test in thromboelastography in trauma replacement therapy[J]. Thromb & Haemost, 2022, 28(6): 1209-1213.

钟林翠, 林青伟, 齐勇, 等. 血栓弹力图纤维蛋白原功能试验在创伤替代治疗中的应用研究[J]. 血栓与止血学, 2022, 28(6): 1209-1213.

Zeng QB, Song JC, Hu W, et al. Clinical study on the use of thromboelastography to guide platelet transfusion indications in severe trauma[J]. Chin J Tran, 2019, 32(10): 1004-1007.

曾庆波, 宋景春, 胡炜, 等. 严重创伤时应用血栓弹力图指导血小板输注指征的临床研究[J]. 中国输血杂志, 2019, 32(10): 1004-1007.

Nagrebetsky A, Al-Samkari H, Davis NM, et al. Perioperative thrombocytopenia: evidence, evaluation, and emerging therapies[J]. Br J Anaesth, 2019, 122(1): 19-31.

Holme PA, Tjønnfjord GE, Batorova A. Continuous infusion of coagulation factor concentrates during intensive treatment[J]. Haemophilia, 2018, 24(1): 24-32.

Zhou FH, Song Q, Pan L, et al. Application of continuous blood purification in the treatment of heat stroke patients with multiple organ dysfunction syndrome [J]. Biomed Engin Clin, 2010, 14(2): 114-117.

周飞虎, 宋青, 潘亮, 等. 持续血液净化在热射病合并多器官功能障碍综合征治疗中应用[J]. 生物医学工程与临床, 2010, 14(2): 114-117.

Ikeda Y, Sakemi T, Nishihara G, et al. Efficacy of blood purification therapy for heat stroke presenting rapid progress of multiple organ dysfunction syndrome: a comparison of five cases[J]. Intensive Care Med, 1999, 25(3): 315-318.

Lumlertgul N, Hall A, Camporota L, et al. Clearance of inflammatory cytokines in patients with septic acute kidney injury during renal replacement therapy using the EMiC2 filter (Clic-AKI study)[J]. Crit Care, 2021, 25(1): 39.

Zou FQ, Tang XH, Lei XH, et al. Treatment efficacy of continuous renal replacement on symptoms, inflammatory mediators, and coagulation function in patients with Sepsis-associated acute kidney injury[J]. Arch Esp Urol, 2022, 75(9): 746-752.

Fay L, Rechner-Neven G, Hammond DA, et al. Evaluating the risk of developing thrombocytopenia within five days of continuous renal replacement therapy initiation in septic patients[J]. J Pharm Pract, 2022, 35(1): 94-100.

Liver Failure and Artificial Hepatology Group, Infectious Disease Society of Chinese Medical Association, Liver Disease Society of Chinese Medical Association, Severe Liver Disease and Artificial Hepatology Group. Guidelines for diagnosis and treatment of liver failure (2018 edition)[J]. Chin J Infect Dis, 2019, 37(1): 1-9.

中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 中华传染病杂志, 2019, 37(1): 1-9.

Inoue N, Sato A, Ikawa Y, et al. Successful treatment of exertional heat stroke using continuous plasma diafiltration[J]. J Clin Apher, 2016, 31(5): 490-492.

Serious Liver Disease and Artificial Liver Group of Hepatology Branch of Chinese Medical Association. Expert consensus on clinical application of artificial liver blood purification technology (2022 Edition)[J]. J Prac Liver Dis, 2022, 25(3): 457-468.

中华医学会肝病学分会重型肝病与人工肝学组. 人工肝血液净化技术临床应用专家共识(2022年版)[J]. 实用肝脏病杂志, 2022, 25(3): 457-468.

Schwartz J, Winters JL, Padmanabhan A, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue[J]. J Clin Apher, 2013, 28(3): 145-284.

Zhou K, Lu EF, Xiao Q, et al. Analysis of plasma exchange combined with continuous blood purification in the treatment of multiple organ dysfunction syndrome caused by heat stroke[J]. Chin J Inte Trad West Neph, 2015, 16(8): 721-723.

周刊, 陆恩峰, 肖琦, 等. 血浆置换联合连续性血液净化在热射病导致多器官功能障碍综合征的救治分析[J]. 中国中西医结合肾病杂志, 2015, 16(8): 721-723.

Wang XY, Song Q, Zhou FH, et al. The application of plasma exchange in patients with heat stroke combined with multiple organ dysfunction syndrome[J]. Chin J Emer Med, 2007, 27(1): 83-85.

王秀英, 宋青, 周飞虎, 等. 血浆置换在热射病合并多器官功能障碍综合征患者中的应用[J]. 中国急救医学, 2007, 27(1): 83-85.

Zhang YN, Dong R, Li Y, et al. Efficacy and safety of plasma diafiltration: review of case reports and case series[J]. Ther Apher Dial, 2023, 27(1): 3-11.

Nanchal R, Subramanian R, Karvellas CJ, et al. Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU: cardiovascular, endocrine, hematologic, pulmonary, and renal considerations[J]. Crit Care Med, 2020, 48(3): e173-e191.

Patel PA, Wyrobek JA, Butwick AJ, et al. Update on applications and limitations of perioperative tranexamic acid[J]. Anesth Analg, 2022, 135(3): 460-473.

Morrison JJ, Dubose JJ, Rasmussen TE, et al. Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study[J]. Arch Surg, 2012, 147(2): 113-119.

Matsumoto H, Takeba J, Umakoshi K, et al. Successful treatment for disseminated intravascular coagulation (DIC) corresponding to phenotype changes in a heat stroke patient[J]. J Intensive Care, 2019, 7: 2.

Peterson K. The development of central venous access device flushing guidelines utilizing an evidence-based practice process[J]. J Pediatr Nurs, 2013, 28(1): 85-88.

Alizadehasl A, Ziyaeifard M, Peighambari M, et al. Avoiding heparinization of arterial line and maintaining acceptable arterial waveform after cardiac surgery: a randomized clinical trial[J]. Res Cardiovasc Med, 2015, 4(3): e28086.